Home  |  Contact

UniProtKB/Swiss-Prot Q17R60: Variant p.Leu238Arg

Interphotoreceptor matrix proteoglycan 1
Gene: IMPG1
Variant information

Variant position:  238
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Leucine (L) to Arginine (R) at position 238 (L238R, p.Leu238Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (L) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In VMD4.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  238
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  797
The length of the canonical sequence.

Location on the sequence:   KMPTTERETEFAVLEEQRVE  L SVSLVNQKFKAELADSQSPY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KMPTT------ERETEFAVLEE----QRVELSVSLVNQKFKAELADSQSPY

Mouse                         QKPTT------ESKTEPIHVSEFSSEEKVEFSISLPNHRFK

Rat                           QTPIAIRRAELESKPEPTHVTEISSEEKVEFSISLPNHRFK

Bovine                        RVPTR------ERKIEFTDAAEDALEQKVELSISLANQKFK

Chicken                       KTPVK--------ELGTNTVPELPAEQMVEFSVTLTDQEYT

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 21 – 797 Interphotoreceptor matrix proteoglycan 1
Domain 232 – 354 SEA 1
Alternative sequence 226 – 797 Missing. In isoform 2.


Literature citations

Mutations in IMPG1 cause vitelliform macular dystrophies.
Manes G.; Meunier I.; Avila-Fernandez A.; Banfi S.; Le Meur G.; Zanlonghi X.; Corton M.; Simonelli F.; Brabet P.; Labesse G.; Audo I.; Mohand-Said S.; Zeitz C.; Sahel J.A.; Weber M.; Dollfus H.; Dhaenens C.M.; Allorge D.; De Baere E.; Koenekoop R.K.; Kohl S.; Cremers F.P.; Hollyfield J.G.; Senechal A.; Hebrard M.; Bocquet B.; Ayuso Garcia C.; Hamel C.P.;
Am. J. Hum. Genet. 93:571-578(2013)
Cited for: INVOLVEMENT IN VMD4; VARIANTS VMD4 PRO-154 AND ARG-238;

Frequency and clinical pattern of vitelliform macular dystrophy caused by mutations of interphotoreceptor matrix IMPG1 and IMPG2 genes.
Meunier I.; Manes G.; Bocquet B.; Marquette V.; Baudoin C.; Puech B.; Defoort-Dhellemmes S.; Audo I.; Verdet R.; Arndt C.; Zanlonghi X.; Le Meur G.; Dhaenens C.M.; Hamel C.P.;
Ophthalmology 121:2406-2414(2014)
Cited for: VARIANT VMD4 ARG-238;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.